Practical Supplement Protocols
Given the complexity, here are evidence-informed starting points organized by symptom cluster and budget.
1 Minimal Cost Protocol (Under $30/month)
For patients with limited resources:
- Electrolytes: Salt + potassium salt (Nu-Salt) + DIY rehydration ($5/month)
- Magnesium glycinate: 200–400 mg at bedtime ($10/month)
- B-complex: Basic B-complex with methylated B12/folate ($10/month)
- Vitamin D3: 2000–5000 IU daily ($5/month)
This addresses the most common deficiencies and supports autonomic function. All components are Category A (net energy providers) or B (energy-neutral), making this protocol safe for all severity levels including very severe patients. See Section Treatment Trials as Energy Gambles for the energy category framework.
2 Moderate Protocol ($50–100/month)
Adding mitochondrial and antioxidant support. Severity note: For moderate-to-severe patients, establish the minimal protocol for at least 4 weeks before adding these supplements. NADH and CoQ10 may be introduced together as a pair (consistent with the Castro-Marrero protocol); introduce each subsequent supplement individually with 1–2 week observation windows. All additions are Category A or B.
- Everything in minimal protocol, plus:
- NADH + CoQ10 (ubiquinol): 20 mg NADH + 200 mg CoQ10 daily—the Castro-Marrero protocol (Castro-Marrero et al. 2021) ($40–60/month combined)
- NAC: 600–1200 mg daily ($10–15/month)
- Omega-3: 2 g EPA/DHA daily ($15–20/month)
- D-ribose: 5–10 g daily ($15–20/month)
3 Comprehensive Protocol ($100–200/month)
For mild-to-moderate patients who can afford broader support. Severity note: For severe and very severe patients, this protocol should only be attempted after documented tolerance of the moderate protocol over 8+ weeks. Physician supervision recommended. While all components are Category A–B, the cumulative hepatic processing load of multiple supplements warrants caution in energy-depleted patients (see Section Developing a Treatment Plan).
- Everything above, plus:
- NR or NMN: 300–500 mg daily ($40–60/month)
- Acetyl-L-carnitine: 1000 mg daily ($15/month)
- Alpha-lipoic acid: 300 mg daily ($10/month)
- Curcumin (enhanced): 500 mg daily ($15–20/month)
4 By Symptom Cluster
Predominant Orthostatic Symptoms.
- Electrolytes (priority)
- Magnesium
- Taurine (mechanistic rationale only; no ME/CFS trial evidence; see Section:taurine)
- Licorice root (caution: raises BP)
Predominant Cognitive Symptoms.
- NADH + CoQ10 (cognitive fatigue improvement; Castro-Marrero 2021 RCT, n=207)
- Magnesium L-threonate
- Acetyl-L-carnitine
- Omega-3 (high DHA)
- NR/NMN
- Creatine
Predominant Immune/Inflammatory Symptoms.
- NAC
- Omega-3
- Curcumin
- Quercetin (especially if mast cell component)
- Vitamin D (optimize)
Predominant Muscle/Fatigue Symptoms.
- NADH + CoQ10 (electron transport chain support; Section D-Ribose Evidence Quality)
- D-ribose (ATP backbone resynthesis)
- L-carnitine (fatty acid transport into mitochondria)
- Creatine (rapid ATP buffering via phosphocreatine)
- Magnesium malate (cofactor for >300 enzymatic reactions; malate feeds the TCA cycle)
5 Introduction Strategy
ME/CFS patients often have multiple sensitivities (clinical experience). Introducing multiple supplements simultaneously makes it impossible to identify what helps or harms. Start one new supplement at a time, at low dose, and wait 1–2 weeks before adding another. Keep a symptom diary.
Suggested Order.
- Electrolytes and magnesium (foundational; generally well-tolerated with gradual titration—see Section Histamine Intolerance and Electrolyte Products)
- B vitamins (essential cofactors)
- CoQ10 + NADH (exception to the one-at-a-time principle: the RCT evidence is for the combination, not the individual components; see Section D-Ribose Evidence Quality). NADH requires an empty stomach 30–60 min before breakfast; CoQ10 is taken with a fat-containing meal—these timing constraints naturally separate the two supplements
- NAC (antioxidant; watch for sulfur sensitivity)
- Additional mitochondrial support (NAD+ precursors, D-ribose, ALCAR) based on response
6 Architecture C “Reserve Builder” Stack
Standard ME/CFS mitochondrial supplement protocols (CoQ10 + NADH + D-ribose) target electron transport chain throughput (\(J_\text{production,max}\)). Architecture C suggests a complementary approach targeting the UPSTREAM bottlenecks that determine why metabolic reserve is low in neurodivergent patients — cofactor supply, enzyme efficiency, and rapid-access energy buffers.
| Component | Target | Dose | Rationale |
|---|---|---|---|
| Iron bisglycinate | Complex I/II + dopamine synthesis | Titrate to ferritin \(> 100\) ng/mL | Dual bottleneck |
| Folinic acid (5-MTHF) | BH4 recycling support | 400–800 mcg | Supports DHFR-mediated BH4 regeneration |
| Vitamin C | BH4 oxidation protection + dopamine beta-hydroxylase cofactor | 500–1000 mg | Prevents BH4 → BH2 oxidation |
| Zinc | Dopamine receptor function + SOD cofactor | 15–30 mg | Documented deficiency in ADHD |
| Magnesium threonate | NMDA modulation + mito cofactor + BBB-crossing | 144 mg elemental Mg (as threonate) | Brain-bioavailable form |
| Creatine monohydrate | Phosphocreatine buffer (rapid ATP regeneration) | 3–5 g/day | Extends time before ATP depletion reaches critical level |
Distinction from standard protocols. This stack focuses on upstream bottlenecks (cofactor supply, enzyme efficiency, phosphocreatine buffer) rather than downstream ETC support. The two approaches are complementary and may be combined. Estimated cost: ~$80/month. The biochemical rationales for each component are individually grounded but the combination has never been tested — the specificity of mechanism-target mapping should not be mistaken for clinical validation.
Individual components have evidence for their specific targets, but the combination has never been tested. Interaction effects between components are unknown. This protocol should not replace evidence-based ME/CFS management. Start one component at a time (2-week intervals) to identify individual tolerability and response. Adherence burden is substantial: 6 supplements atop any existing protocol (CoQ10, NADH, D-ribose) creates a 9+ daily supplement load. Energy-limited patients with cognitive impairment may find this impractical — prioritize iron and creatine (highest evidence and actionability) if full adherence is unrealistic. Consult a physician before initiating multi-supplement protocols, particularly regarding iron dosing.
Certainty: 0.30. The combined upstream approach — simultaneously addressing iron status, BH4 recycling, antioxidant protection, phosphocreatine buffering, and neurotransmitter cofactors — should produce greater cognitive and energy improvement in neurodivergent ME/CFS patients than standard mitochondrial protocols targeting only ETC throughput. Testable by comparing the Reserve Builder stack vs standard CoQ10 + NADH + D-ribose protocol in a crossover design (\(n = 40\), neurodivergent ME/CFS). Individual components have moderate evidence; the combination is untested. Not yet replicated.